Earnings summaries and quarterly performance for ALTRIA GROUP.
Executive leadership at ALTRIA GROUP.
William F. Gifford, Jr.
Detailed
Chief Executive Officer
CEO
Heather A. Newman
Detailed
Senior Vice President, Chief Strategy and Growth Officer
Jody L. Begley
Detailed
Executive Vice President and Chief Operating Officer
Robert A. McCarter III
Detailed
Executive Vice President and General Counsel
Salvatore Mancuso
Detailed
Executive Vice President and Chief Financial Officer
Board of directors at ALTRIA GROUP.
Debra J. Kelly-Ennis
Detailed
Director
Ellen R. Strahlman
Detailed
Director
George Muñoz
Detailed
Director
Ian L.T. Clarke
Detailed
Director
Kathryn B. McQuade
Detailed
Chair of the Board
M. Max Yzaguirre
Detailed
Director
Marjorie M. Connelly
Detailed
Director
R. Matt Davis
Detailed
Director
Richard S. Stoddart
Detailed
Director
Virginia E. Shanks
Detailed
Director
Research analysts who have asked questions during ALTRIA GROUP earnings calls.
Bonnie Herzog
Goldman Sachs
6 questions for MO
Also covers: CASY, CCEP, CELH +21 more
Eric Serotta
Morgan Stanley
4 questions for MO
Also covers: CCEP, CELH, COCO +5 more
Matthew Smith
Analyst
4 questions for MO
Also covers: BRBR, E, GIS +14 more
Emma Rumney
Reuters
3 questions for MO
Gaurav Jain
Barclays
3 questions for MO
Also covers: BTI, PM, SW
Mirza Faham Baig
UBS
3 questions for MO
Also covers: PM
Faham Baig
UBS Group
2 questions for MO
Also covers: BTI, PM
Callum Elliott
Bernstein
1 question for MO
Also covers: HLN, PM, UL
Damian McNeela
Deutsche Numis
1 question for MO
Also covers: BTI, PM
Gerald Pascarelli
Needham & Company
1 question for MO
Also covers: AGFY, CELH, COCO +8 more
Matthew Edward Smith
Stifel
1 question for MO
Also covers: SMPL
Matt Smith
Bank of America
1 question for MO
Also covers: BRBR, GIS, HAIN +7 more
Mirza Faham Ali Baig
UBS Investment Bank
1 question for MO
Recent press releases and 8-K filings for MO.
Altria Q3 2025 EPS up 3.6%, doubles share repurchase
MO
Earnings
Share Buyback
Guidance Update
- Adjusted diluted EPS rose 3.6% to $1.45, outperforming expectations despite a 3% decline in net revenues to about $6.1 billion
- Expanded its share repurchase program from $1 billion to $2 billion through 2026
- Declared its 60th consecutive dividend increase, underscoring strong shareholder returns
- Narrowed full-year 2025 adjusted EPS guidance to $5.37–$5.45, forecasting moderated Q4 performance
Oct 30, 2025, 5:27 PM
Altria reports Q3 2025 results
MO
Earnings
Guidance Update
Share Buyback
- Q3 adjusted diluted EPS grew 3.6% year-over-year, and smokeable products adjusted OCI increased 0.7% to nearly $3 billion with margins expanding to 64.4%.
- Reported domestic cigarette volumes declined 8.2% (adjusted ~9%), Marlboro’s premium share rose to 59.6%, discount brand Basic captured over half of the discount-segment growth, and cigar shipments increased 2%.
- Oral tobacco segment adjusted OCI dipped <1% while margins expanded 2.4 pp to 69.2%; ON shipment volume grew 1% to 42 million cans and ON’s retail share was 8.7% of the oral category.
- Launched premium ON+ in Florida, North Carolina, and Texas; ON+ PMTA applications included in FDA’s new oral pouch pilot; Horizon filed combined PMTA/MRTPA for Ploom heated tobacco; and initiated strategic collaboration with KT&G on international modern oral and U.S. non-nicotine products.
- Raised 2025 adjusted EPS guidance to $5.37–$5.45 (up 3.5–5%), increased the quarterly dividend 3.9% to $1.06, and expanded the share repurchase program to $2 billion through 2026.
Oct 30, 2025, 1:00 PM
Altria reports Q3 2025 earnings and shareholder returns
MO
Earnings
Dividends
Share Buyback
- Adjusted diluted EPS of $1.45, a 3.6% year-over-year increase
- Quarterly dividend raised 3.9% to $1.06 per share, totaling $5.2 billion in dividends and $712 million in buybacks YTD, with repurchase program expanded to $2 billion
- Smokeable Products segment adjusted OCI of $2,956 million, up 0.7% yoy; total industry cigarette volume declined 9.0% in Q3
- Oral Tobacco Products volume fell 9.6% yoy to 178.2 million cans, while on! shipment volume edged up to 42.2 million cans
Oct 30, 2025, 1:00 PM
Altria reports Q3 2025 results
MO
Earnings
Guidance Update
Dividends
- Delivered 3.6% adjusted diluted EPS growth in Q3 and 5.9% for the first nine months; raised FY 2025 EPS guidance to $5.37–$5.45, with Q4 growth expected to moderate as share count benefits and MSA legal fund expirations lap.
- Smokeable products’ adjusted OCI rose 0.7% to $3 billion with margins expanding to 64.4%, while reported domestic cigarette volumes declined 8.2% (9% adjusted); Marlboro premium share reached 59.6% and Basic gained 1.4 ppts YOY, supporting a 45.4% total cigarette retail share.
- Oral tobacco segment saw ON shipments grow 1% to 42 million cans in Q3 (15% for nine months), with segment retail share at 31.1% and Q3 adjusted OCI down <1%; launched premium ON+ in FL, NC, and TX and included in the FDA’s PMTA pilot for nicotine pouches.
- Increased quarterly dividend by 3.9% to $1.06 and expanded share repurchase authorization to $2 billion through 2026; federal agencies seized over 4 million illicit vapor units, reinforcing Altria’s support for stronger regulatory enforcement.
Oct 30, 2025, 1:00 PM
Altria reports Q3 2025 results and strategic updates
MO
Earnings
Guidance Update
Product Launch
- Altria delivered strong Q3 financial performance, with adjusted diluted EPS up 3.6% versus Q3 2024 and 5.9% growth for the first nine months; smokeable products’ adjusted OCI grew 0.7% to nearly $3 billion in Q3, with margins expanding to 64.4%.
- The company raised the low end of its 2025 EPS guidance to a range of $5.37–$5.45, reflecting continued momentum despite anticipated Q4 headwinds from share count and MSA fund lapses.
- Altria reaffirmed its commitment to shareholder returns, increasing its quarterly dividend by 3.9% to $1.06 (60th increase in 56 years) and expanding its share repurchase authorization to $2 billion through end-2026.
- Portfolio progress included growth in nicotine pouches (“on!” shipments +1% to 42 million cans), the launch of on! PLUS in three states, FDA PMTA/MRTPA filings for Ploom heated tobacco, and ongoing e-vapor patent litigation developments.
- A new collaboration with KT&G aims to expand modern oral products (including investment in LOOP snus), explore U.S. non-nicotine opportunities, and leverage duty-drawback efficiencies for international cigarette manufacturing.
Oct 30, 2025, 1:00 PM
Altria reports Q3 2025 results and narrows FY 2025 guidance
MO
Earnings
Guidance Update
Share Buyback
- In Q3 2025, net revenues declined 3.0% to $6.07 billion while adjusted diluted EPS rose 3.6% to $1.45 (nine-month adjusted EPS of $4.12, up 5.9%).
- Altria narrowed its full-year 2025 adjusted diluted EPS guidance to $5.37–$5.45, representing 3.5%–5.0% growth from $5.19 in 2024; it also expects a 23%–24% adjusted tax rate and $175–$225 million of capital expenditures.
- The company repurchased 1.9 million shares in Q3 at an average price of $60.13 for $112 million (12.3 million shares YTD for $712 million) and expanded its buyback program to $2 billion through December 31, 2026.
- In August, Altria declared its 60th consecutive annual dividend increase, raising the annualized rate to $4.24 per share and paying $1.7 billion in Q3 dividends.
Oct 30, 2025, 11:03 AM
Altria raises quarterly dividend by 3.9% to $1.06
MO
Dividends
Guidance Update
- Altria Group increased its quarterly dividend by 3.9% to $1.06, annualized to $4.24 with a 6.3% yield
- Marks the 60th dividend increase in 56 years, supporting its mid-single-digit growth target through 2028
- Dividend payable on October 10, 2025 to shareholders of record as of September 15, 2025
- 2025 EPS guidance raised to $5.35–$5.45, driven by growth in oral tobacco products
Aug 21, 2025, 5:34 PM
Altria issues $1B senior unsecured notes
MO
Debt Issuance
- On August 6, 2025, Altria Group, Inc. issued $500 million of 4.500% Notes due 2030 and $500 million of 5.250% Notes due 2035, settling on August 6, 2025.
- The Notes are fully and unconditionally guaranteed by Philip Morris USA Inc. and rank equally with all existing and future senior unsecured debt of both issuers.
- Interest is payable semi-annually on February 6 and August 6, beginning February 6, 2026, to holders of record on the preceding January 22 or July 22.
- The Notes are callable at 100% of principal (par) or a make-whole amount prior to specified dates and include a change-of-control repurchase at 101% of principal plus accrued interest.
Aug 6, 2025, 12:00 AM
Altria Group Reports Q1 2025 Results & Earnings Update
MO
Earnings
Guidance Update
Share Buyback
- Q1 Financial Results: Net revenues reached $5.3B (down 5.7%), with reported diluted EPS at $0.63 (down 47.9%) and adjusted diluted EPS at $1.23 (up 6.0%) .
- Guidance Reaffirmed: Full-year adjusted diluted EPS is projected between $5.30–$5.45 (reflecting 2–5% growth over 2024) .
- Capital Returns: Returned capital included approximately $1.7B in dividends and $326M in share repurchases (with an additional $674M remaining), also noting repurchase of 5.7M shares .
- Smokeable Segment Performance: Adjusted operating income grew by 2.7% despite a 12% decline in domestic cigarette volumes, with margins improving from 60.2 to 64.4 .
- Oral Tobacco Highlights: The on! brand saw shipments rise from 33.3M to 39.3M, U.S. market share climb from 7.0% to 8.8%, and Helix shipping over 39 million cans .
- E-Vapor Update: A noncash goodwill impairment of $873M was recorded, reflecting adjustments in its e-vapor portfolio .
Apr 29, 2025, 1:01 PM
Quarterly earnings call transcripts for ALTRIA GROUP.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more